Bile Leak Clinical Trial
— LDLTxOfficial title:
Effectiveness and Sensitivity of White Test Versus Conventional Saline Test in Minimizing Biliary Leak in Partial Liver Resection in Living Donor Liver Transplant
Verified date | June 2020 |
Source | Ain Shams University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Biliary leak is a common complication after partial liver resection in living donor liver
transplant. It debases the quality of the postoperative course and affects morbidity and
mortality. Detecting and localizing sites of biliary leak intraoperatively through bile
leakage testing is important as it helps in detection of bile leaking points on the cut
surface and decrease post-operative bile leak.
In this study we will assess the efficacy and sensitivity of using White test in comparison
to conventional saline test in detecting intra operative bile leakage in liver donor.
The White test uses fat emulsion (SMOFLIPID), which is a lipid emulsion with a lipid content
of 0.2 grams/mL in 100 mL, 250 mL, and 500 Ml that is normally used for parenteral nutrition,
for localization of bile leakage. The use of fat emulsion in bile leakage tests does not
require special equipment, contaminate the wound, cause allergic reaction or damage the bile
duct and surrounding tissues.
Status | Completed |
Enrollment | 60 |
Est. completion date | June 20, 2020 |
Est. primary completion date | June 15, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria:patients who are candidate for liver donation) Criteria for donor of
living donor liver transplantation): 1. Potential donors must be healthy volunteers between the ages of 18 and 45 years. 2. BMI must be up to 28. 3. Blood group must be compatible; Rh compatibility was not a significant criterion. 4. Donors should have normal liver function and no medical comorbidities. 5. Liver biopsy was done to ensure that there is no occult hepatic pathology and to establish the degree of steatosis that should be less than 20%. 6. Donors must have no history of upper abdominal surgery. Exclusion Criteria: Intra operative vascular or biliary complication. |
Country | Name | City | State |
---|---|---|---|
Egypt | Ain Shams University | Cairo |
Lead Sponsor | Collaborator |
---|---|
Amr Abdelaal |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intra-operative detection of bile leak points | Detection and suturing of bile leak points | Immediate Intra-operative | |
Secondary | post-operative bile leak | post-operative bile leak - Biloma | Early post-operative (one month) | |
Secondary | Surgical site infection | Infected biloma | Early post-operative (one month) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03753880 -
Hemopatch for Prevention of Bile Leaks After Liver Resection
|
N/A | |
Enrolling by invitation |
NCT03103139 -
Endoscopic Stenting Across the Papilla Versus the Leak Site to Treat Bile Leak
|
N/A | |
Recruiting |
NCT05141942 -
The Need for Repeat ERCP After Endoscopic Treatment of Postsurgical Biliary Leaks
|
||
Recruiting |
NCT04665427 -
Bile Leaks After Biliary Surgery
|
N/A | |
Completed |
NCT04477005 -
Archimedes Bio-degradable Bile Duct Stent Study
|
||
Completed |
NCT03673033 -
Biliary Complications in Live Donor Liver Transplantation
|
||
Recruiting |
NCT01438385 -
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
|
N/A | |
Terminated |
NCT03333382 -
Plastic vs. Fully Covered Self Expanding Stents (FCSEMS) for Treatment of Anastomotic Bile Leaks
|
N/A | |
Recruiting |
NCT02545153 -
Fibrin Sealant for Cholangiotomy Closure Study
|
Phase 2 | |
Completed |
NCT02056028 -
Bile Leak After Liver Surgery
|
N/A | |
Not yet recruiting |
NCT06181318 -
Quantitative MRI and Outcomes of Liver Resection
|
||
Not yet recruiting |
NCT05705557 -
Efficacy of ABSOLOKā¢ Clip System-RFP-2021-01 in Open Liver Resection
|
||
Not yet recruiting |
NCT03166683 -
Standard of Care Versus Hemopatch® During Liver Resection
|
N/A |